Literature DB >> 18480080

Does gender influence the patency of infrainguinal bypass grafts?

Ufuk Alpagut1, Murat Ugurlucan, Maciej Banach, Dimitri P Mikhailidis, Enver Dayioglu.   

Abstract

Infrainguinal revascularization is an effective method of treatment for femoropopliteal/tibial occlusive diseases. However, these bypass grafts are prone to stenosis. In this retrospective study, the authors investigate the association of gender with patency of infrainguinal bypass grafts. The outcomes for consecutive 375 male and 200 female patients who underwent infrainguinal bypass surgery for arterial occlusive disease are compared, and associations with characteristics of the patients, surgical procedure, and graft stenosis are determined. It is found that several demographic, biochemical, and etiological factors could influence the patency of bypass procedures in different genders. However, infrainguinal arterial reconstruction procedures performed in women have a worse outcome when compared with that in men.

Entities:  

Mesh:

Year:  2008        PMID: 18480080     DOI: 10.1177/0003319708316898

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  3 in total

1.  The influence of gender on functional outcomes of lower extremity bypass.

Authors:  Reshma P Duffy; Julie E Adams; Peter W Callas; Andres Schanzer; Philip P Goodney; Michael A Ricci; Jack L Cronenwett; Daniel J Bertges
Journal:  J Vasc Surg       Date:  2014-09-19       Impact factor: 4.268

2.  Surgical treatment of lower limb ischemia in diabetic patients - long-term results.

Authors:  Bekir Inan; Unal Aydin; Murat Ugurlucan; Cemalettin Aydin; Melike Elif Teker
Journal:  Arch Med Sci       Date:  2013-12-18       Impact factor: 3.318

3.  Outcome of intra-arterial thrombolysis in patients with diabetes and acute lower limb ischemia: a propensity score adjusted analysis.

Authors:  Talha Butt; Anders Gottsäter; Jan Apelqvist; Gunnar Engström; Stefan Acosta
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.